40.66
price up icon3.88%   1.52
after-market 시간 외 거래: 40.90 0.24 +0.59%
loading
전일 마감가:
$39.14
열려 있는:
$38.66
하루 거래량:
1.01M
Relative Volume:
2.24
시가총액:
$2.63B
수익:
$87.56M
순이익/손실:
$-167.47M
주가수익비율:
-14.73
EPS:
-2.76
순현금흐름:
$-148.20M
1주 성능:
-3.49%
1개월 성능:
-7.70%
6개월 성능:
+30.03%
1년 성능:
+65.96%
1일 변동 폭
Value
$38.24
$40.77
1주일 범위
Value
$37.09
$44.17
52주 변동 폭
Value
$22.35
$53.27

Kymera Therapeutics Inc Stock (KYMR) Company Profile

Name
명칭
Kymera Therapeutics Inc
Name
전화
857-285-5314
Name
주소
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
Name
직원
184
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
KYMR's Discussions on Twitter

KYMR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KYMR
Kymera Therapeutics Inc
40.66 2.63B 87.56M -167.47M -148.20M -2.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Kymera Therapeutics Inc Stock (KYMR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-10 개시 BTIG Research Buy
2024-12-06 개시 BMO Capital Markets Market Perform
2024-12-02 업그레이드 Wells Fargo Equal Weight → Overweight
2024-11-18 개시 Stephens Overweight
2024-09-09 재개 Leerink Partners Outperform
2024-08-26 업그레이드 Wolfe Research Peer Perform → Outperform
2024-04-22 개시 Oppenheimer Outperform
2024-02-15 개시 Wolfe Research Peer Perform
2024-01-04 업그레이드 JP Morgan Neutral → Overweight
2024-01-03 다운그레이드 BofA Securities Buy → Neutral
2023-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-06-30 개시 Truist Buy
2023-05-05 업그레이드 Raymond James Mkt Perform → Outperform
2022-12-06 다운그레이드 Credit Suisse Outperform → Neutral
2022-11-08 개시 Raymond James Mkt Perform
2022-08-15 개시 Jefferies Buy
2022-08-03 개시 Goldman Buy
2022-07-20 개시 SVB Leerink Mkt Perform
2022-04-28 개시 Credit Suisse Outperform
2022-03-10 개시 JP Morgan Neutral
2022-02-10 개시 Wells Fargo Overweight
2021-09-30 개시 B. Riley Securities Neutral
2021-09-30 개시 Stifel Buy
2021-09-10 다운그레이드 BofA Securities Buy → Neutral
2021-05-21 개시 UBS Buy
2021-04-14 개시 Berenberg Buy
2020-12-04 개시 H.C. Wainwright Buy
2020-09-15 개시 BofA Securities Neutral
2020-09-15 개시 Cowen Outperform
2020-09-15 개시 Guggenheim Buy
2020-09-15 개시 Morgan Stanley Equal-Weight
모두보기

Kymera Therapeutics Inc 주식(KYMR)의 최신 뉴스

pulisher
Dec 21, 2024

HighTower Advisors LLC Takes $494,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

BMO Capital Initiates Coverage of Kymera Therapeutics (KYMR) with Market Perform Recommendation - MSN

Dec 20, 2024
pulisher
Dec 17, 2024

BTIG Initiates Coverage of Kymera Therapeutics (KYMR) with Buy Recommendation - MSN

Dec 17, 2024
pulisher
Dec 17, 2024

State Street Corp Has $81.79 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 17, 2024
pulisher
Dec 16, 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Sold by Verition Fund Management LLC - Defense World

Dec 16, 2024
pulisher
Dec 15, 2024

(KYMR) Investment Analysis - Stock Traders Daily

Dec 15, 2024
pulisher
Dec 10, 2024

Kymera Therapeutics (NASDAQ:KYMR) Now Covered by BTIG Research - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Two Sigma Advisers LP Lowers Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Wellington Management Group LLP Has $218.59 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Kymera Therapeutics (NASDAQ:KYMR) Research Coverage Started at BMO Capital Markets - Defense World

Dec 09, 2024
pulisher
Dec 07, 2024

Kymera: Protein Degradation Could Drive Dupixent-Like Value (NASDAQ:KYMR) - Seeking Alpha

Dec 07, 2024
pulisher
Dec 06, 2024

BMO Capital Markets Initiates Coverage on Kymera Therapeutics (NASDAQ:KYMR) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Thrivent Financial for Lutherans Takes $313,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Dec 06, 2024
pulisher
Dec 06, 2024

The Manufacturers Life Insurance Company Has $6.07 Million Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Dec 06, 2024
pulisher
Dec 05, 2024

BMO sets Kymera Therapeutics target at $55, rates Market Perform By Investing.com - Investing.com Canada

Dec 05, 2024
pulisher
Dec 05, 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is Redmile Group LLC's 5th Largest Position - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

(KYMR) Long Term Investment Analysis - Stock Traders Daily

Dec 04, 2024
pulisher
Dec 04, 2024

Bamco Inc. NY Invests $1.18 Million in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Erste Asset Management GmbH Acquires New Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Kymera therapeutics director Pamela Esposito sells shares worth $122,500 By Investing.com - Investing.com Nigeria

Dec 03, 2024
pulisher
Dec 03, 2024

Kymera therapeutics director Pamela Esposito sells shares worth $122,500 - Investing.com India

Dec 03, 2024
pulisher
Dec 03, 2024

12,743 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Purchased by HighVista Strategies LLC - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Cinctive Capital Management LP Acquires Shares of 56,801 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Kymera Therapeutics shares rating upgraded on positive outlook By Investing.com - Investing.com Canada

Dec 03, 2024
pulisher
Dec 03, 2024

Kymera Therapeutics (NASDAQ:KYMR) Upgraded by Wells Fargo & Company to Overweight Rating - Defense World

Dec 03, 2024
pulisher
Dec 02, 2024

Wells Fargo Upgrades Kymera Therapeutics (KYMR) - MSN

Dec 02, 2024
pulisher
Dec 02, 2024

Wells Fargo sees this biotech stock rallying 75% in its bull case - Head Topics

Dec 02, 2024
pulisher
Dec 02, 2024

Fred Alger Management LLC Invests $859,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Fmr LLC Boosts Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

Intech Investment Management LLC Invests $650,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Intech Investment Management LLC Makes New $650,000 Investment in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Dec 01, 2024
pulisher
Nov 30, 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Bought by Eventide Asset Management LLC - MarketBeat

Nov 30, 2024
pulisher
Nov 28, 2024

14,378 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Bought by Natixis Advisors LLC - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Natixis Advisors LLC Purchases Shares of 14,378 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Nov 28, 2024
pulisher
Nov 26, 2024

Kymera Therapeutics announces proposed underwritten offering - MSN

Nov 26, 2024
pulisher
Nov 26, 2024

Kymera Therapeutics to Participate in Upcoming December Investor Conferences - The Manila Times

Nov 26, 2024
pulisher
Nov 26, 2024

Kymera Therapeutics to Present at Major Healthcare Investment Conferences in December | KYMR Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 26, 2024

Massachusetts Financial Services Co. MA Purchases 47,507 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Nov 26, 2024
pulisher
Nov 24, 2024

(KYMR) Trading Report - Stock Traders Daily

Nov 24, 2024
pulisher
Nov 22, 2024

Jennison Associates LLC Purchases 368,394 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat

Nov 22, 2024
pulisher
Nov 20, 2024

Stephens Begins Coverage on Kymera Therapeutics (NASDAQ:KYMR) - Defense World

Nov 20, 2024
pulisher
Nov 18, 2024

Kymera Therapeutics (NASDAQ:KYMR) Coverage Initiated by Analysts at Stephens - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

US Bancorp DE Sells 651 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World

Nov 18, 2024
pulisher
Nov 15, 2024

Kymera Therapeutics (NASDAQ:KYMR) Shares Down 6.7%Here's What Happened - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Avoro Capital Advisors LLC Expands Stake in Kymera Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Long Term Trading Analysis for (KYMR) - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Bolsters Stake in Kymera Therapeutics Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives $51.21 Average Price Target from Analysts - Defense World

Nov 12, 2024
pulisher
Nov 10, 2024

Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $49.00 at Morgan Stanley - Defense World

Nov 10, 2024
pulisher
Nov 09, 2024

Analysts Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) Target Price at $51.21 - MarketBeat

Nov 09, 2024

Kymera Therapeutics Inc (KYMR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):